The emergence of antimicrobial resistance in enterococci isolates from infants: A review study


  • Asem A. Shehabi The Jordan University, Amman
  • Eman Badran
  • Nazha A. Alnasra



Enterococci resistance, VRE, Infants, Jordan


The emergence of antibiotic resistance in potential bacterial pathogens is considered as an important consequence of antibiotic misuse and overuse in humans and animals husbandry. In addition,  lacks of adequate infection-control practice in hospital and medical care settings have led to the continuing development of extensive resistance problems worldwide. Certain multidrug-resistant commensal and potential pathogens are now   widely spread in community and hospital patients worldwide . Examples are meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistance enterococcci (VRE), extended-spectrum β-lactamase- and carbapenemase-producing coliforms, and toxin-hyperproducing Clostridium difficile. During the last decade, Enterococcus faecalis and Enterococcus faecium are the most prevalent species cultured from human infections. Incidence of enterococci resistant to multiple antibiotics has become increasingly common in the hospitalized patients all over the world. E. faecium is reported to be responsible for most vancomycin-resistant enterococci (VRE) infections.


Author Biographies

Asem A. Shehabi, The Jordan University, Amman

Department of Pathology-Microbiolog, professor

Eman Badran

The University of Jordan, Faculty of Medicine

Nazha A. Alnasra

Pathology-Microbiology, Faculty of Medicine, The University of Jordan, Amman, Jordan


K Orrhage, CE Nord . Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl 1999; 88: 47–57.

Miller WR , JM Munita, CA Arias. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014;12(10):1221-36.

Furtado I , Xavier PCN, LVM Tavares, F Alves , SF Martins, et al. Enterococcus faecium and Enterococcus faecalis in blood of newborns with suspected nosocomial infection, J Instit Trop Med Sao Paulo 2014; 56(1): 77-80.

Werner G, I Klare, C Fleige, U Geringer, W Witte, et al. Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU. Antimicrob Resist Infect Cont 2012; 1: 21.

Arias CA, BE Murray. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012; 16:266-78.

Van Schaik W, RJ Willems. Genome-based insights into the evolution of enterococci. Clin Microbiol Infect 2010; 16(6):527-32.

Hollenbeck BL, LB Rice. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 2012; 3: 421-569.

Rice LB. Antimicrobial resistance in gram-positive bacteria, American J Infect Cont. 2012; 34: S11-S19.

Chow J. Aminoglycoside resistance in enterococci, Clin Infect Dis 2000; 31:586 -9.

Wood AJ. Vancomycin resistant enterococcal infections. N Engl J Med 2000; 342:710-720.

Chavers LS. Vancomycin resistant enterococci: 15years and counting. J Hosp Infect 2003;53:159-171.

CLSI (2012), Performance Standards for Antimicrobial Susceptibility Testing, Twentieth InformationalSupplement, Wayne, PA: Clinical and Laboratory Standards Institute. CLSI document M100-S20.

Shankar N, AS Baghdayan, MS Gilmore. Modulation of virulence within a pathogenicity island in vancomycin resistant Enterococcus faecalis. Nature 2002; 417:746–750.

Cariolato D, C Andrighetto, A Lombardi . Occurrence of virulence factors and antibiotic resistances in Enterococcus faecalis and Enterococcus faecium collected from dairy and human samples in North Italy. Food Control 2008; 19: 886–892.

Tacconelli E, MA Cataldo. Review of vancomycin-resistant enterococci (VRE): transmission and control. Int J Antimicrob Agents 2008; 31:99-106.

Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology 2009; 155: 1749-57.

Deshpande LM, TR Fritsche TR, GJ Moet, et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58(2):163-70.

Yameen MA. S Iram, S Abdul Mannan, S Ali Khan, N Akhtar. Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities, BioMed Cent Infect Dis 2013;13:156.

Ochoa SA, G Escalona, A Cruz-Córdova, LB Dávila, Z Saldaña, et al. Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City, BMC Microbiol 2013; 11:13-291.

Kirtzalidou EI,EK Mitsou, P Pramateftaki, A Kyriacou. Screening Fecal Enterococci from Greek Healthy Infants for Susceptibility to Antimicrobial Agents. Microb Drug Resist 2012; 18(6): 578-585.

Hufnagel M, C Liese, C Loescher, M Kunze, H Proempeler, et al. (2007), Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns, BioMed Cent Infect Dis 2007; 7:107.

Dahlen G, S Blomqvist , A Almstahl, A Carlen . Virulence factors and antibiotic susceptibility in enterococci isolated from oral mucosal and deep infections. J Microbiol 2012; 4:10.

Solheim M, A Aakra, LG Snipen, I Nes. Comparative genomics of Enterococcus faecalis from healthy Norwegian infants, BioMed Cent Genom 2009; 10: 194-205.

Hashem YA, AS Yassin , MA Amin . Molecular characterization of Enterococcus spp. clinical isolates from Cairo, Egypt. Indian J Med Microbiol. 2015; 33 Suppl:S80-6.

Shorman M, J A Al-Tawfiq. Risk Factors Associated with Vancomycin-Resistant Enterococcus in Intensive Care Unit Settings in Saudi Arabia. Interdiscip Perspect Infect Dis 2013, ID 369674, 4 pages.

Araj GF, AZ Avedissian , NS Ayyash, AH Bey , GR El Asmar, et al. A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade. J Med Liban 2012; 60 (3): 125-35.

Salem-Bekhit MM. IM Moussa, MM Muharram, FK Alanazy, MH Hefni. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens, Indian J Med Microbiol 2012; 30:44-51.

Hijazi N. AA Elmanama, A Al-Hindi. Vancomycin-resistant enterococci in fecal samples from hospitalized patients and non-hospitalized individuals in Gaza City. J Public Health 2009; 17:243–249.

Mahafzah A, I Abu-Khader, F Bakri. Characterization of Enterococci Causing Nosocomial Infections at the Jordan University Hospital Over a Five-year Period. Jordan Med J 2008;42 (4): 229-237.

Salah R. N Dar-Odeh, O Abu Hammad, AA Shehabi. (2008), Prevalence of putative virulence factors and antimicrobial susceptibility of E. faecalis isolates from patients with dental Diseases, BioMed Cent Oral Health 2008; 8:17.

Klibi N , K Ben Slama , Y Sáenz , A Masmoudi , S Zanetti, et al. . Detection of virulence factors in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolates from a Tunisian hospital. Can J Microbiol 2007; 53(3):372-9.

Udo, E.E. N Al-Sweih, AO Phillips, TD Chugh. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals, J Med Microbiol 2003; 52:163-8

Pranita DT, AJ. Hsu. Optimizing Therapy for Vancomycin-resistant Enterococcal Bacteremia in Children. Curr Opin Infect Dis 2014; 27(6):517-527.

Garazzino S , Tovo PA. Clinical experience with linezolid in infants and children. J Antimicrob Chemother 2011;66 Suppl 4:iv23-iv41







Most read articles by the same author(s)

1 2 > >>